BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced its support for World Hypoparathyroidism Awareness Day. This observance encourages patients, physicians, and caregivers to increase awareness of hypoparathyroidism and the need for more education, improved diagnosis, and new, long-term treatments for this rare and complex disorder.
